Amarin Corp Plc (AMRN)

[ggwpq]

For those worry about patents, don't worry. Amarin's patents are novel and non-obvious as JT explained below:

John Thero

Yes, so we have over 50 patents, most of them are not related to the molecules. So what we have is a surprisingly unexpected findings that are specific to our labels. So that for example, and there are -- there were four Endo filers, so one backed out early, two terribly stuck with and wo remained, and [indiscernible]. We were at, sort of, 14 of Orange Book listed patents against those and those patents deal with the surprising and unexpected findings associated with our first through our Phase III studies, which is the genesis of our current label. And they are -- the patents are around, I'll just give one example. I think all those patents are terrific, but one example is, patenting the use of highly pure eicosapentaenoic acid for the treatment of patients who had triglyceride levels greater than 500 resulting in triglyceride reduction without increasing cholesterol and that's unique from the perspective that even if you put patients with very high triglycerides and diet. Their cholesterol tends to go up. Lovaza, in that population, the cholesterol went up by 49% and consistently, it seem -- cholesterol go up in that population. So being able to show something different for that was deemed to be unique and the Endo filers have acknowledged that where they'd have generic product but they would infringe that patent is central to our -- it's central to our labels. So that, just an example of 1 claim and 1 patent.

https://seekingalpha.com/article/4248486-amarin-corporation-plc-amrn-presents-cowen-health-care-broker-conference-call-transcript